Author

B. S. Walker

Newcastle University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:proteomics· 2 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

M. H. Wong· 2 shared A Whittaker· 1 shared A. Gower· 1 shared A. H. Skalet· 1 shared A. Sapre· 1 shared A. Sattler· 1 shared Adrian FreemaniD· 1 shared Alex von Kreigsheim· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

M. H. Wong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacological inhibition of 11βhydroxysteroid dehydrogenase type 1 after myocardial infarction targets extracellular matrix processing and preserves cardiac function in a translational mini-pig model

Sara Al Disi, Raimondo Ascione, Shazia Khan, TW Johnson, Eva C. Sammut, Vito Domenico Bruno, Daniel Baz-Lopez, Carol-Ann James, Joanna P. Simpson, Natalie Z M Homer, MIchael Millar, Trisha Singh, Alex von Kreigsheim, Nick L. Mills, B. S. Walker, , Gillian A. Gray

This study shows that inhibiting 11βHSD1 after myocardial infarction preserves cardiac function and prevents adverse remodelling in a mini-pig model.

British Journal of Pharmacology · Dec 28, 2025Peer-reviewedPharmacology & Toxicology

Magnetic Levitation and Sorting of Neoplastic Circulating Cell Hybrids

K. Liang, S. Yaman, R. K. Patel, M. S. Parappilly, B. S. Walker, M. H. Wong, N. G. Durmus

This paper develops a magnetic levitation method to isolate neoplastic circulating hybrid cells from blood samples without surface marker dependence, demonstrating its feasibility for unbiased enrichment.

bioRxiv · Nov 3, 2022 · PreprintBioengineering

Relevance of Circulating Hybrid Cells as a Non-Invasive Biomarker for Myriad Solid Tumors

M. S. Dietz, T. L. Sutton, B. S. Walker, C. E. Gast, L. Zarour, S. K. Sengupta, J. R. Swain, J. Eng, M. Parappilly, K. Limbach, A. Sattler, E. Burlingame, Y. Chin, A. Gower, J. L. Montoya Mira, , M. H. Wong

This study identifies circulating hybrid cells (CHCs) as a novel biomarker for metastatic solid tumors, showing they outnumber CTCs and exhibit tumor-initiating properties across multiple cancer types.

bioRxiv · Mar 11, 2021 · PreprintCancer Biology